Posts by category Drug Science it https://www.mind-foundation.org/blog/it/category/category/drug-science/blog.category.xml Fri, 10 Jul 2026 13:24:06 +0200 https://www.mind-foundation.org/blog/it/symposium-episodeMon, 28 Oct 2024 13:57:15 +0100Henrik Jungaberlehttps://www.mind-foundation.org/blog/it/symposium-episode https://www.mind-foundation.org/blog/it/the-apt-networkTue, 24 Sep 2024 12:06:13 +0200Max Wolffhttps://www.mind-foundation.org/blog/it/the-apt-networkDiscover how the MIND Foundation's Augmented Psychotherapy Training (APT) Network is creating a professional community for psychedelic therapists. With 142 members and growing, the network provides valuable support, collaboration, and development opportunities, advancing the integration of psychedelic therapy into mental health care worldwide. https://www.mind-foundation.org/blog/it/5-meo-dmt-syntheticThu, 28 Jul 2022 11:08:00 +0200Johannes ReckwegLukas A. Basedowhttps://www.mind-foundation.org/blog/it/5-meo-dmt-synthetic5-MeO-DMT & its effects: safety, dosage & therapeutic potential. Learn more in the interview with Johannes Reckweg! ► Read now! https://www.mind-foundation.org/blog/it/field-pharmacologyWed, 01 Dec 2021 09:26:00 +0100Malin Vedøy UthaugLucca Jaeckelhttps://www.mind-foundation.org/blog/it/field-pharmacologyEntdecken Sie die faszinierende Welt der Feld-Pharmakologie & wie naturalistische Placebos die psychedelische Therapie beeinflussen. ► Mehr erfahren! https://www.mind-foundation.org/blog/it/tolerance-to-lsdSat, 16 Oct 2021 00:01:00 +0200Tobias Buchbornhttps://www.mind-foundation.org/blog/it/tolerance-to-lsd https://www.mind-foundation.org/blog/it/mdma-ptsdFri, 03 Sep 2021 16:40:00 +0200Samuli Kangaslampi, Ph.D.https://www.mind-foundation.org/blog/it/mdma-ptsdTitle: Exploring the Potential of MDMA-Assisted Psychotherapy for PTSD Treatment Summary: The article discusses the promising potential of MDMA-assisted psychotherapy as a treatment for posttraumatic stress disorder (PTSD), particularly for patients who have not found success with traditional methods. It highlights the limitations of previous pharmacological approaches and introduces MDMA as a novel and more promising augmentation to psychotherapy. Key Points: 1. **Current PTSD Treatment Strategies**: The article emphasizes trauma-focused psychological therapies as the most effective for treating PTSD. However, dropout rates and limited effectiveness still pose challenges. 2. **Introduction of MDMA-Assisted Psychotherapy**: MDMA-assisted psychotherapy is presented as a promising alternative. It suggests that MDMA may help patients engage more effectively in therapy and facilitate the processing of traumatic memories, potentially leading to symptom reduction. 3. **Mechanisms of Action Shared with Other Treatments**: The article discusses how MDMA may work through mechanisms shared with other treatments, such as promoting adaptive changes in trauma-related beliefs and inhibiting fear reactions. 4. **Possible Unique Mechanisms**: Additionally, the article speculates on unique mechanisms of action specific to MDMA-assisted psychotherapy, including increases in openness and the facilitation of breakthrough insights. 5. **Future Directions**: The article calls for further research, including trials comparing MDMA-assisted psychotherapy to existing treatments and exploring psychological mechanisms of change. It suggests that understanding these mechanisms could lead to the development of even more effective treatments. 6. **Conclusion**: In conclusion, the article underscores the potential of MDMA-assisted psychotherapy in enhancing PTSD treatment outcomes and advocates for continued research and development in this area. By summarizing these key points and optimizing for SEO and social media, you can create a concise and engaging overview of the article's content, making it more accessible and shareable on digital platforms. https://www.mind-foundation.org/blog/it/psychedelic-neuroscience-antidepressantFri, 25 Jun 2021 12:13:00 +0200Vlad Nicolescuhttps://www.mind-foundation.org/blog/it/psychedelic-neuroscience-antidepressantIs a "psychedelic trip" needed for the therapeutic benefits of psychedelics? Explore this controversy and a neuroscientific case arguing in favor. https://www.mind-foundation.org/blog/it/psychedelics-alzheimers-disease-treatmentSat, 12 Jun 2021 01:52:00 +0200Milena Marinkovićhttps://www.mind-foundation.org/blog/it/psychedelics-alzheimers-disease-treatment https://www.mind-foundation.org/blog/it/antidepressants-neurobiologyFri, 28 May 2021 16:09:00 +0200Lukas A. BasedowEero Castrénhttps://www.mind-foundation.org/blog/it/antidepressants-neurobiology https://www.mind-foundation.org/blog/it/psychedelic-phases-neuroscienceFri, 26 Mar 2021 13:40:00 +0100Dea Siggaard StenbækLukas A. Basedowhttps://www.mind-foundation.org/blog/it/psychedelic-phases-neuroscience